Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
Orme ME, Bentley R, Marcella S, Peck-Radosavljevic M, Perard R, Wedemeyer H, Yoshiji H, Agarwal K, Dusheiko G. Orme ME, et al. Among authors: yoshiji h. Adv Ther. 2022 Sep;39(9):4169-4188. doi: 10.1007/s12325-022-02235-w. Epub 2022 Jul 14. Adv Ther. 2022. PMID: 35836089 Free PMC article.
Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.
Tsuji Y, Kawaratani H, Ishida K, Kaya D, Kubo T, Fujinaga Y, Sawada Y, Takaya H, Shimozato N, Kaji K, Namisaki T, Moriya K, Akahane T, Yoshiji H. Tsuji Y, et al. Among authors: yoshiji h. Dig Dis. 2020;38(4):329-334. doi: 10.1159/000504044. Epub 2019 Oct 25. Dig Dis. 2020. PMID: 31655803 Clinical Trial.
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease.
Kong Y, Lv T, Li M, Zhao L, Meng T, Wu S, Wei W, Zhang Q, Chen S, You H, Lens S, Yoshiji H, Francque S, Tsochatzis E, Sarin SK, Mandorfer M, Jia J; BAVENO Cooperation: an EASL consortium. Kong Y, et al. Among authors: yoshiji h. Hepatol Int. 2022 Oct;16(5):1052-1063. doi: 10.1007/s12072-022-10369-w. Epub 2022 Sep 9. Hepatol Int. 2022. PMID: 36083440
[Current drug therapy for hepatocellular carcinoma].
Yoshiji H. Yoshiji H. Nihon Shokakibyo Gakkai Zasshi. 2022;119(5):389-402. doi: 10.11405/nisshoshi.119.389. Nihon Shokakibyo Gakkai Zasshi. 2022. PMID: 35545537 Japanese. No abstract available.
[Cirrhosis up to date -advances in therapeutic approaches].
Yoshiji H. Yoshiji H. Nihon Shokakibyo Gakkai Zasshi. 2024;121(5):343-355. doi: 10.11405/nisshoshi.121.343. Nihon Shokakibyo Gakkai Zasshi. 2024. PMID: 38735742 Review. Japanese. No abstract available.
420 results